Bioage Labs Stock Market Value
| BIOA Stock | 22.32 0.18 0.81% |
| Symbol | BioAge |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAge Labs. Projected growth potential of BioAge fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BioAge Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate BioAge Labs using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BioAge Labs' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause BioAge Labs' market price to deviate significantly from intrinsic value.
It's important to distinguish between BioAge Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioAge Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BioAge Labs' market price signifies the transaction level at which participants voluntarily complete trades.
BioAge Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAge Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAge Labs.
| 11/28/2025 |
| 02/26/2026 |
If you would invest 0.00 in BioAge Labs on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding BioAge Labs or generate 0.0% return on investment in BioAge Labs over 90 days. BioAge Labs is related to or competes with Lifecore Biomedical, Canopy Growth, Allogene Therapeutics, Editas Medicine, Alpha Teknova, Aurora Cannabis, and Atea Pharmaceuticals. BioAmber Inc., an industrial biotechnology company, produces and sells renewable chemicals worldwide More
BioAge Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAge Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioAge Labs upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.32 | |||
| Information Ratio | 0.2535 | |||
| Maximum Drawdown | 33.5 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 13.88 |
BioAge Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAge Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAge Labs' standard deviation. In reality, there are many statistical measures that can use BioAge Labs historical prices to predict the future BioAge Labs' volatility.| Risk Adjusted Performance | 0.2176 | |||
| Jensen Alpha | 1.66 | |||
| Total Risk Alpha | 0.8758 | |||
| Sortino Ratio | 0.4745 | |||
| Treynor Ratio | 11.43 |
BioAge Labs February 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2176 | |||
| Market Risk Adjusted Performance | 11.44 | |||
| Mean Deviation | 4.3 | |||
| Semi Deviation | 2.53 | |||
| Downside Deviation | 3.32 | |||
| Coefficient Of Variation | 368.98 | |||
| Standard Deviation | 6.21 | |||
| Variance | 38.61 | |||
| Information Ratio | 0.2535 | |||
| Jensen Alpha | 1.66 | |||
| Total Risk Alpha | 0.8758 | |||
| Sortino Ratio | 0.4745 | |||
| Treynor Ratio | 11.43 | |||
| Maximum Drawdown | 33.5 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 13.88 | |||
| Downside Variance | 11.02 | |||
| Semi Variance | 6.38 | |||
| Expected Short fall | (5.59) | |||
| Skewness | 1.87 | |||
| Kurtosis | 4.91 |
BioAge Labs Backtested Returns
BioAge Labs is not too volatile given 3 months investment horizon. BioAge Labs secures Sharpe Ratio (or Efficiency) of 0.25, which signifies that the company had a 0.25 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.61% are justified by taking the suggested risk. Use BioAge Labs Mean Deviation of 4.3, risk adjusted performance of 0.2176, and Downside Deviation of 3.32 to evaluate company specific risk that cannot be diversified away. BioAge Labs holds a performance score of 19 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.15, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioAge Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding BioAge Labs is expected to be smaller as well. Use BioAge Labs total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to analyze future returns on BioAge Labs.
Auto-correlation | -0.04 |
Very weak reverse predictability
BioAge Labs has very weak reverse predictability. Overlapping area represents the amount of predictability between BioAge Labs time series from 28th of November 2025 to 12th of January 2026 and 12th of January 2026 to 26th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioAge Labs price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current BioAge Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 1.05 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether BioAge Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioAge Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioage Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioage Labs Stock:Check out BioAge Labs Correlation, BioAge Labs Volatility and BioAge Labs Performance module to complement your research on BioAge Labs. For information on how to trade BioAge Stock refer to our How to Trade BioAge Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
BioAge Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.